Mindpeak Expands to the United States with New Headquarters in Boston

We are proud to announce the official launch of Mindpeak Inc. in Boston, establishing our new US headquarters at the heart of the world’s leading pharma, biotech, and diagnostics ecosystem.
This milestone represents more than the opening of an office. It reflects our commitment to collaborating closely with innovators across the United States to:
- Accelerate biomarker discovery and companion diagnostics
- Advance the development of cancer therapies
- Enable faster, more precise matching of treatments to patients
With a permanent presence in the US, we are making advanced AI-powered pathology part of everyday workflows—providing reproducible, high-quality insights that transform complex data into better patient outcomes.
At Mindpeak, we look forward to building strong partnerships and shaping the future of precision medicine together.
Read the full article here
You may also be interested in
Find out more about our AI-based diagnostics
